Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Nepafenac in Reducing Macular Volume After Epiretinal Membrane Surgery

NCT00818844 is registered in ClinicalTrials.gov with Alcon Research as lead sponsor.

NCT NCT00818844
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00818844 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Nepafenac in Reducing Macular Volume After Epiretinal Membrane Surgery
Lead sponsor
Alcon Research
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2009
Completion date
June 30, 2010
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epiretinal membrane